Results 241 to 250 of about 1,543,350 (297)

Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease.

open access: yesJ Clin Endocrinol Metab
Miyamura K   +8 more
europepmc   +1 more source

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

open access: yesJ Clin Endocrinol Metab
Wolf J   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy